Order Article Reprints

Ye S-Y, Li J-Y, Li T-H, Song Y-X, Sun J-X, Chen X-W, Zhao J-H, Li Y, Wu Z-H, Gao P, et al. The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Oncology. 2022; 29(9):6137-6153. https://doi.org/10.3390/curroncol29090482

Ye, Shi-Yu, Jia-Yi Li, Teng-Hui Li, Yong-Xi Song, Jing-Xu Sun, Xiao-Wan Chen, Jun-Hua Zhao, Yuan Li, Zhong-Hua Wu, Peng Gao, and et al. 2022. "The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" Current Oncology 29, no. 9: 6137-6153. https://doi.org/10.3390/curroncol29090482

Ye, S.-Y., Li, J.-Y., Li, T.-H., Song, Y.-X., Sun, J.-X., Chen, X.-W., Zhao, J.-H., Li, Y., Wu, Z.-H., Gao, P., & Huang, X.-Z. (2022). The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Oncology, 29(9), 6137-6153. https://doi.org/10.3390/curroncol29090482